newsfilter
← Latest News
GlobeNewswire·

Bright Minds Biosciences Announces BMB‑201 Outperforms Sumatriptan in Validated Preclinical Vascular Headache Model

NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ:DRUG) today announced compelling preclinical results for its investigational compound BMB‑201, in a validated isosorbide dinitrate